190 related articles for article (PubMed ID: 31626733)
1. Stochastic Protein Alkylation by Antimalarial Peroxides.
Jourdan J; Walz A; Matile H; Schmidt A; Wu J; Wang X; Dong Y; Vennerstrom JL; Schmidt RS; Wittlin S; Mäser P
ACS Infect Dis; 2019 Dec; 5(12):2067-2075. PubMed ID: 31626733
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel).
Jourdan J; Matile H; Reift E; Biehlmaier O; Dong Y; Wang X; Mäser P; Vennerstrom JL; Wittlin S
ACS Infect Dis; 2016 Jan; 2(1):54-61. PubMed ID: 26819968
[TBL] [Abstract][Full Text] [Related]
3. Ozonide Antimalarials Alkylate Heme in the Malaria Parasite
Giannangelo C; Anderson D; Wang X; Vennerstrom JL; Charman SA; Creek DJ
ACS Infect Dis; 2019 Dec; 5(12):2076-2086. PubMed ID: 31622078
[TBL] [Abstract][Full Text] [Related]
4. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
5. A Click Chemistry-Based Proteomic Approach Reveals that 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile.
Ismail HM; Barton VE; Panchana M; Charoensutthivarakul S; Biagini GA; Ward SA; O'Neill PM
Angew Chem Int Ed Engl; 2016 May; 55(22):6401-5. PubMed ID: 27089538
[TBL] [Abstract][Full Text] [Related]
6. Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts
Giannangelo C; Stingelin L; Yang T; Tilley L; Charman SA; Creek DJ
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263074
[TBL] [Abstract][Full Text] [Related]
7. Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.
Fügi MA; Wittlin S; Dong Y; Vennerstrom JL
Antimicrob Agents Chemother; 2010 Mar; 54(3):1042-6. PubMed ID: 20028825
[TBL] [Abstract][Full Text] [Related]
8. Peroxide Antimalarial Drugs Target Redox Homeostasis in
Siddiqui G; Giannangelo C; De Paoli A; Schuh AK; Heimsch KC; Anderson D; Brown TG; MacRaild CA; Wu J; Wang X; Dong Y; Vennerstrom JL; Becker K; Creek DJ
ACS Infect Dis; 2022 Jan; 8(1):210-226. PubMed ID: 34985858
[No Abstract] [Full Text] [Related]
9. System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion.
Giannangelo C; Siddiqui G; De Paoli A; Anderson BM; Edgington-Mitchell LE; Charman SA; Creek DJ
PLoS Pathog; 2020 Jun; 16(6):e1008485. PubMed ID: 32589689
[TBL] [Abstract][Full Text] [Related]
10. Heme as trigger and target for trioxane-containing antimalarial drugs.
Meunier B; Robert A
Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
[TBL] [Abstract][Full Text] [Related]
11.
Straimer J; Gnädig NF; Stokes BH; Ehrenberger M; Crane AA; Fidock DA
mBio; 2017 Apr; 8(2):. PubMed ID: 28400526
[TBL] [Abstract][Full Text] [Related]
12. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research.
Patel OPS; Beteck RM; Legoabe LJ
Eur J Med Chem; 2021 Mar; 213():113193. PubMed ID: 33508479
[TBL] [Abstract][Full Text] [Related]
13. Ozonide Antimalarial Activity in the Context of Artemisinin-Resistant Malaria.
Giannangelo C; Fowkes FJI; Simpson JA; Charman SA; Creek DJ
Trends Parasitol; 2019 Jul; 35(7):529-543. PubMed ID: 31176584
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7.
Ismail HM; Barton V; Phanchana M; Charoensutthivarakul S; Wong MH; Hemingway J; Biagini GA; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2080-5. PubMed ID: 26858419
[TBL] [Abstract][Full Text] [Related]
15. Identification of an antimalarial synthetic trioxolane drug development candidate.
Vennerstrom JL; Arbe-Barnes S; Brun R; Charman SA; Chiu FC; Chollet J; Dong Y; Dorn A; Hunziker D; Matile H; McIntosh K; Padmanilayam M; Santo Tomas J; Scheurer C; Scorneaux B; Tang Y; Urwyler H; Wittlin S; Charman WN
Nature; 2004 Aug; 430(7002):900-4. PubMed ID: 15318224
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.
Yang T; Xie SC; Cao P; Giannangelo C; McCaw J; Creek DJ; Charman SA; Klonis N; Tilley L
Antimicrob Agents Chemother; 2016 Aug; 60(8):4501-10. PubMed ID: 27161632
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial Effect of 3-Methoxy-1,2-Dioxetanes on the Erythrocytic Cycle of Plasmodium falciparum.
Lopes NS; Yoshitake AM; Silva AF; Oliveira VX; Silva LS; Pinheiro AA; Ciscato LF
Chem Biol Drug Des; 2015 Dec; 86(6):1373-7. PubMed ID: 26032859
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts/phosphatidylcholine.
Bousejra-El Garah F; Wong MH; Amewu RK; Muangnoicharoen S; Maggs JL; Stigliani JL; Park BK; Chadwick J; Ward SA; O'Neill PM
J Med Chem; 2011 Oct; 54(19):6443-55. PubMed ID: 21888440
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the malaria parasite using an arterolane-like scaffold.
Fontaine SD; Spangler B; Gut J; Lauterwasser EM; Rosenthal PJ; Renslo AR
ChemMedChem; 2015 Jan; 10(1):47-51. PubMed ID: 25314098
[TBL] [Abstract][Full Text] [Related]
20. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
Dong Y; Wittlin S; Sriraghavan K; Chollet J; Charman SA; Charman WN; Scheurer C; Urwyler H; Santo Tomas J; Snyder C; Creek DJ; Morizzi J; Koltun M; Matile H; Wang X; Padmanilayam M; Tang Y; Dorn A; Brun R; Vennerstrom JL
J Med Chem; 2010 Jan; 53(1):481-91. PubMed ID: 19924861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
